Led by Biochemistry professor Zongchao Jia, an expert in protein crystallography, the team’s focus is on an enzyme called tyrosine kinase derived from bacteria. “For years, bacteria were thought to have less sophisticated signaling systems than those found in mammals,” says Dr. Jia, Canada Research Chair in Structural Biology. “But now we know that isn’t true.”
The findings are published in the prestigious journal, EMBO J, and are featured as an Editors’ Choice in the current edition of Science. Also on the team from the Queen’s Biochemistry Department are Daniel Lee and Jimin Zheng, and Dr. Yi-Min She from the Chemistry Department.
The Queen's team created a crystal that provided the first glimpse of the elusive kinase structure. This is considered a milestone as the bacterial enzyme shows a completely different structure from kinases found in mammals.
Kinases are enzymes responsible for regulating or controlling a protein's function, most often acting as a switch signal between "on" and "off". By adding the appropriate amount of phosphate to its own protein "tail" this particular enzyme will turn on. Using the same strategy, the enzyme regulates the assembly of the protective bacterial capsule, which also contributes to antibiotic resistance.
Finding the crystal that would explain this process proved to be a considerable challenge, the researchers acknowledge. A laboratory at the University of Michigan, pursuing the same crystal, sent a letter of congratulations when they learned the Queen’s lab had succeeded first. “That doesn’t always happen in our competitive world!” says Dr. Jia with a laugh.
Source: Queens University
Related stories:
Researchers discover that SLC2A9 is a high-capacity urate transporter in humans
An international team of researchers led by Professors Mark Caulfield and Patricia Munroe, from the William Harvey Research Institute at Barts and The London School of Medicine and Dentistry with Chris Cheeseman at the University of Alberta in Canada and Kelle Moley at the University of Washington in USA, have shown that the SLC2A9 gene, which encodes a glucose transporter, is also a high-capacity urate transporter, and thus possibly a new drug target for gout. Their findings are published in this week's
PLoS Medicine (7 October 2008).
Early-stage gene transcription creates access to DNA
A gene contained in laboratory yeast has helped an international team of researchers uncover new findings about the process by which protein molecules bind to control sequences in genes in order to initiate gene expression, according to findings reported in the journal
Nature.
Medicine award kicks off Nobel Prize announcements
(AP) -- Two scientists who have won acclaim for research into the growth of cancer cells could be candidates for the Nobel Prize in medicine when the 2008 winners are presented on Monday, kicking off six days of Nobel announcements.
Food for thought -- regulating energy supply to the brain during fasting
If the current financial climate has taught us anything, it's that a system where over-borrowing goes unchecked eventually ends in disaster. It turns out this rule applies as much to our bodies as it does to economics. Instead of cash, our body deals in energy borrowed from muscle and given to the brain.
Groundbreaking discovery may lead to stronger antibiotics
The last decade has seen a dramatic decline in the effectiveness of antibiotics, resulting in a mounting public health crisis across the world. A new breakthrough by University of Virginia researchers provides physicians and patients a potential new approach toward the creation of less resistant and more effective antibiotics.
Beginning to see the light
(PhysOrg.com) -- Scientists have detailed the active form of a protein which they hope will enhance our understanding of the molecular mechanisms of vision, and advance drug design.
Natural Viagra? 'Horny goat weed' shows promise in lab studies
Move over, Viagra! Researchers in Italy report that an ancient Chinese herbal remedy known as "horny goat weed" shows potential in lab studies as source for new future drugs to treat erectile dysfunction (ED). The study, which provides scientific evidence supporting the herb's well-known use as a natural aphrodisiac, is scheduled for the October 24 issue of ACS'
Journal of Natural Products.
'Hub' of fear memory formation identified in brain cells
A protein required for the earliest steps in embryonic development also plays a key role in solidifying fear memories in the brains of adult animals, scientists have revealed. An apparent "hub" for changes in the connections between brain cells, beta-catenin could be a potential target for drugs to enhance or interfere with memory formation.
